- Home
- HROW vs GSL Comparison
HROW vs GSL Comparison
Compare HROW & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- GSL
- Stock Information
- Founded
- HROW 1998
- GSL 2007
- Country
- HROW United States
- GSL Greece
- Employees
- HROW N/A
- GSL N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- GSL Marine Transportation
- Sector
- HROW Health Care
- GSL Consumer Discretionary
- Exchange
- HROW Nasdaq
- GSL Nasdaq
- Market Cap
- HROW 1.1B
- GSL 972.2M
- IPO Year
- HROW N/A
- GSL 2006
- Fundamental
- Price
- HROW $33.02
- GSL $30.36
- Analyst Decision
- HROW Strong Buy
- GSL Strong Buy
- Analyst Count
- HROW 7
- GSL 1
- Target Price
- HROW $61.83
- GSL $33.00
- AVG Volume (30 Days)
- HROW 453.8K
- GSL 350.9K
- Earning Date
- HROW 08-11-2025
- GSL 08-05-2025
- Dividend Yield
- HROW N/A
- GSL 6.92%
- EPS Growth
- HROW N/A
- GSL 18.97
- EPS
- HROW N/A
- GSL 10.70
- Revenue
- HROW $212,858,000.00
- GSL $730,277,000.00
- Revenue This Year
- HROW $46.17
- GSL $4.15
- Revenue Next Year
- HROW $39.97
- GSL N/A
- P/E Ratio
- HROW N/A
- GSL $2.77
- Revenue Growth
- HROW 53.49
- GSL 4.54
- 52 Week Low
- HROW $20.85
- GSL $17.73
- 52 Week High
- HROW $59.23
- GSL $30.98
- Technical
- Relative Strength Index (RSI)
- HROW 48.64
- GSL 73.51
- Support Level
- HROW $30.12
- GSL $27.82
- Resistance Level
- HROW $33.90
- GSL $29.17
- Average True Range (ATR)
- HROW 1.70
- GSL 0.59
- MACD
- HROW -0.50
- GSL 0.03
- Stochastic Oscillator
- HROW 36.39
- GSL 81.90
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About GSL Global Ship Lease Inc New
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.